# Study of AZD9829 in CD123+ Hematological Malignancies

> clinical trial · VERIFIED · 2026-07-01

Status: COMPLETED · Sponsor: AstraZeneca · Condition: Hematological Malignancies

- Company: AstraZeneca
- Sector: oncology
- Primary source: https://clinicaltrials.gov/study/NCT06179511

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.